These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4113183)

  • 1. [Studies of mechanisms of the action of androgens on prostate. 3. Anti-androgenic effect of gestagenic compounds and treatment of benign prostatic hypertrophy with chlormadinone acetate].
    Shida K; Shimazaki J; Urano E; Kurihara H; Takahashi H
    Nihon Hinyokika Gakkai Zasshi; 1972 Feb; 63(2):109-28. PubMed ID: 4113183
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-androgens. Animal experiments and clinical application].
    Neumann F; Steinbeck H
    Internist (Berl); 1971 May; 12(5):198-205. PubMed ID: 4103750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy].
    Umeda K
    Hinyokika Kiyo; 1991 Nov; 37(11):1429-33. PubMed ID: 1722628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
    Fujimoto K; Hirao Y; Ohashi Y; Shibata Y; Fuji K; Tsuji H; Shimizu N; Miyazawa K; Nagata M; Ohtani N; Furuya R; Boku E
    Hinyokika Kiyo; 2011 Apr; 57(4):177-83. PubMed ID: 21646847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
    Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroidal and nonsteroidal antiandrogens: chemical structures, mechanisms of action and clinical applications].
    Akakura K; Furuya Y; Ito H
    Nihon Rinsho; 1998 Aug; 56(8):2124-8. PubMed ID: 9750520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
    Yoshida H; Haraguchi C; Ogawa Y; Kawai N; Ohyama M; Higaki Y; Saitoh T; Imamura K
    Hinyokika Kiyo; 1983 Nov; 29(11):1419-26. PubMed ID: 6203377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
    Murakoshi M; Ikeda R; Fukui N; Nakayama T
    Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Ikeda R; Tagawa M; Nakayama T
    Tokai J Exp Clin Med; 1999 Jun; 24(2):77-83. PubMed ID: 10641996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
    Kazama T; Mizuno I; Takamine T; Umeda K; Terada T; Ishikawa S; Fuse H; Katayama T
    Hinyokika Kiyo; 1990 Dec; 36(12):1423-7. PubMed ID: 1706136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
    Murakoshi M; Ikada R; Tagawa M; Nakayama T
    Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental and clinical study of the anti-prostatic effect of allylestrenol].
    Yamanaka H; Kosaku N; Makino T; Shida K
    Hinyokika Kiyo; 1983 Sep; 29(9):1133-45. PubMed ID: 6203385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antiandrogens on sexual behaviour and gonadal function in male rats.
    Dörner G; Götz F; Mainz K
    Endocrinol Exp; 1972; 6(1):17-27. PubMed ID: 4111333
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
    Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
    Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mechanism of antiandrogenic action of chlormadinone acetate (author's transl)].
    Ito Y; Kurosawa I; Yamanaka H; Koya A; Imai K
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun; 68(6):537-52. PubMed ID: 72181
    [No Abstract]   [Full Text] [Related]  

  • 18. [The value of anti-androgens in dermatology].
    Winkler K
    Ann Dermatol Syphiligr (Paris); 1968; 95(2):147-53. PubMed ID: 4175248
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the long-term effect of anti-androgen therapy by sonometrics in patients with benign prostatic hypertrophy].
    Kimura A; Higuchi T
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1697-702. PubMed ID: 2471862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiandrogens].
    Stárka L
    Cesk Farm; 1970 Apr; 19(3):116-20. PubMed ID: 4192975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.